Diagnostics360 Sustainability Profile

Diagnostics360 was established as part of the UK's response to the COVID-19 pandemic, initially aiding the government's efforts in managing the crisis through PCR testing. As the pandemic continues, the company has widened its focus to address the significant impacts on the healthcare system, including the prolonged NHS backlog affecting diagnostic procedures for patients. Diagnostics360 offers an array of pathology services across various disciplines such as biochemistry, haematology, immunology, molecular biology, and sexual health screening, all supported by highly experienced staff and advanced technology. This setup ensures rapid results, facilitating quicker patient access to necessary healthcare information.